Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega Jj(Vall d'Hebron Hospital Universitari), L Massuet, Marta Torrabadella(Banc de Sang i Teixits), Pilar Bastida, Luis Armadans(Vall d'Hebron Hospital Universitari), Anna Llort, Cristina Díaz de Heredia(Universitat Autònoma de Barcelona)
PubMed
March 1, 2003
Cited by 21
Related Papers
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
|Haematologica|2014|389
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
|Journal of Allergy and Clinical Immunology|2017|318